Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
A mutation of Ikbkg causes immune deficiency without impairing degradation of IB
Owen M. Siggsa,
Michael Bergera,
Philippe Krebsa,
Carrie N. Arnolda,
Celine Eidenschenka,
Christoph Huberb,
Elaine Piriea,
Nora G. Smarta,
Kevin Khovanantha,
Yu Xiaa,
Gerald McInerneyc,
Gunilla B. Karlsson Hedestamc,
David Nemazeeb, and
Bruce Beutlera,1
Departments of aGenetics and bImmunology, The Scripps Research Institute, La Jolla, CA 92037; and cDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden
Contributed by Bruce Beutler, December 30, 2009 (sent for review December 17, 2009)
Abstract:
Null alleles of the gene encoding NEMO (NF-B essential modulator)are lethal in hemizygous mice and men, whereas hypomorphic allelestypically cause a syndrome of immune deficiency and ectodermaldysplasia. Here we describe an allele of Ikbkg in mice thatimpaired Toll-like receptor signaling, lymph node formation,development of memory and regulatory T cells, and Ig production,but did not cause ectodermal dysplasia. Degradation of IB, whichis considered a primary requirement for NEMO-mediated immunesignaling, occurred normally in response to Toll-like receptorstimulation, yet ERK phosphorylation and NF-B p65 nuclear translocationwere severely impaired. This selective loss of function highlightsthe immunological importance of NEMO-regulated pathways beyondIB degradation, and offers a biochemical explanation for rareimmune deficiencies in man.
Author contributions: O.M.S. and B.B. designed research; O.M.S.,M.B., P.K., C.A., C.E., C.H., E.P., K.K., and Y.X. performedresearch; G.M., G.B.K.H., and D.N. contributed new reagents/analytictools; O.M.S. and B.B. analyzed data; and O.M.S., N.G.S., andB.B. wrote the paper.
1To whom correspondence should be addressed. E-mail: bruce{at}scripps.edu.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
John F. Foley (23 February 2010) Sci. Signal.3 (110), ec61.
[DOI: 10.1126/scisignal.3110ec61] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Recognition of pathogen-associated nucleic acids by endosomal nucleic acid-sensing toll-like receptors.
X. He, H. Jia, Z. Jing, and D. Liu (2013)
Acta Biochim Biophys Sin
45, 241-258
|Abstract »|Full Text »|PDF »
iRhom2 is required for the secretion of mouse TNF{alpha}.
O. M. Siggs, N. Xiao, Y. Wang, H. Shi, W. Tomisato, X. Li, Y. Xia, and B. Beutler (2012)
Blood
119, 5769-5771
|Abstract »|Full Text »|PDF »
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses.
D. E. Zak, F. Schmitz, E. S. Gold, A. H. Diercks, J. J. Peschon, J. S. Valvo, A. Niemisto, I. Podolsky, S. G. Fallen, R. Suen, et al. (2011)
PNAS
108, 11536-11541
|Abstract »|Full Text »|PDF »
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands.
K. Brandl, L. Sun, C. Neppl, O. M. Siggs, S. M. Le Gall, W. Tomisato, X. Li, X. Du, D. N. Maennel, C. P. Blobel, et al. (2010)
PNAS
107, 19967-19972
|Abstract »|Full Text »|PDF »